Shares of Solventum Corp. SOLV rose 1.33% to $75.15 Monday, on what proved to be an all-around favorable trading session for ...

Shares of Solventum Corp. SOLV slipped 2.31% to $72.30 Thursday, on what proved to be an all-around rough trading session for ...

M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson said ...

Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said it would acquire the company’s purification and filtration business for $4.

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System ...

Solventum's fourth-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.

Nelson Peltz’s hedge fund, Trian Fund Management.  Not only did the billionaire sell his firm’s stake in Disney (NYSE:DIS) ...

Mizuho raised the firm’s price target on Solventum (SOLV) to $82 from $70 and keeps a Neutral rating on the shares following the Q4 report. The ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an ...

Adjusted free cash flow significantly declined to $92 million from $459 million in Q4 2023. Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments ...